Given the recent systematic and meta-analysis which concluded that glial-derived neurotrophic factor (GDNF) and neurturin do not improve motor symptoms in people with Parkinson's (Hegarty et al., 2017) it is timely to consider alternative factors that may hold potential. The gene discussed is GDNF; the disease is Parkinsonism.